London – A new study aimed at advancing research in lung cancer has been announced by Oncogene Cancer Research, in collaboration with genetic health and biopharmaceutical company 23andMe Holding Co. and 20 lung cancer advocacy organizations. The Lung Cancer Genetics Study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data in order to improve…
